sem informação173124124sem informaçãosem informação36th World Congress of the International-Society-of-Hematolog
textabstractMultiple Myeloma (MM) is a malignant plasma cell disorder accounting for 1% of all malig...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Santa Casa São Paulo, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniv São Paulo...
Clin Sao Germano, Dept Hematol & Oncol, Sao Paulo, BrazilJanssen Cilag Farmaceut LTDA, Sao Paulo, Br...
Se realizó un estudio donde se determinó el comportamiento epidemiológico del mieloma múltiple en n...
© 2018 Elsevier Inc. Latin American countries represents a large fraction of patients who are treate...
Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, ...
PURPOSEInfections are a significant cause of morbidity and mortality in patients with multiple myelo...
O mieloma múltiplo (MM) caracteriza-se por expansão clonal plasmocitária na medula óssea e produção ...
The incidence of multiple myeloma (MM) is known to be variable according to ethnicity. However, the ...
The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physi...
Artículo de publicación ISIThere are previously reported data describing differences between Asian a...
Before the advent of diagnostic criteria for multiple sclerosis (MS), it was reported that the preva...
The present prospective, multinational, noninterventional study aimed to document and describe real-...
Before the advent of diagnostic criteria for multiple sclerosis (MS), it was reported that the preva...
textabstractMultiple Myeloma (MM) is a malignant plasma cell disorder accounting for 1% of all malig...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Santa Casa São Paulo, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniv São Paulo...
Clin Sao Germano, Dept Hematol & Oncol, Sao Paulo, BrazilJanssen Cilag Farmaceut LTDA, Sao Paulo, Br...
Se realizó un estudio donde se determinó el comportamiento epidemiológico del mieloma múltiple en n...
© 2018 Elsevier Inc. Latin American countries represents a large fraction of patients who are treate...
Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, ...
PURPOSEInfections are a significant cause of morbidity and mortality in patients with multiple myelo...
O mieloma múltiplo (MM) caracteriza-se por expansão clonal plasmocitária na medula óssea e produção ...
The incidence of multiple myeloma (MM) is known to be variable according to ethnicity. However, the ...
The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physi...
Artículo de publicación ISIThere are previously reported data describing differences between Asian a...
Before the advent of diagnostic criteria for multiple sclerosis (MS), it was reported that the preva...
The present prospective, multinational, noninterventional study aimed to document and describe real-...
Before the advent of diagnostic criteria for multiple sclerosis (MS), it was reported that the preva...
textabstractMultiple Myeloma (MM) is a malignant plasma cell disorder accounting for 1% of all malig...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Santa Casa São Paulo, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniv São Paulo...
View in ORKG
DOI